Patents by Inventor Dale Brady

Dale Brady has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150202386
    Abstract: An apparatus has a plunger which is slidably received within a syringe housing between a first and second position. A hall sensor module is disposed on the apparatus. The hall sensor module includes a hall sensor and a magnet slidably disposed relative to the hall sensor.
    Type: Application
    Filed: April 1, 2015
    Publication date: July 23, 2015
    Inventors: Dale Brady, Dustin Kasel
  • Patent number: 8986382
    Abstract: A system and method for securing an implantable medical device to an anatomical feature, such as bony structures and/or soft tissues near the spine. The system includes a tissue fixation device and a tissue fixation device delivery tool. The tissue fixation device includes at least one bone or tissue anchor and a connecting element coupled thereto. The tissue fixation device optionally includes a flexible anchoring strap for engaging the implantable medical device. The bone or tissue anchor are configured to be deployed into the anatomical feature, and the connecting element is tightened to secure the implantable medical device to the anatomical feature.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: March 24, 2015
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Ishmael Bentley, Dale Brady, Emily Daley, Mike E. Lancial, Lawrence W. Wales, Steven L. Griffith
  • Publication number: 20140316462
    Abstract: An intervertebral disc repair system comprises an implant and a delivery tool configured to deploy the implant at least partially in a vertebral body of a patient. The implant includes an anchor member and an adjustable suture assembly coupled thereto. The delivery tool includes a proximal handle, an outer tubular member extending distally from the handle, a needle cannula slidably received within the outer tubular member having a sharpened tip for penetrating tissue (e.g., the vertebral body), an inner pusher member slidably received within the needle cannula, and an actuating mechanism coupled to the handle for selectively retracting the needle cannula relative to the outer tubular member and the inner pusher member. At least the anchor member of the implant is releasably received within the needle cannula.
    Type: Application
    Filed: February 17, 2014
    Publication date: October 23, 2014
    Inventors: Dale Brady, Lawrence W. Wales, Ishmael Bentley
  • Publication number: 20140288422
    Abstract: An apparatus includes a syringe housing and a plunger slidably received within the syringe housing between a first position and a second position. The plunger has a substantially opaque portion and a substantially translucent portion. A light sensor module is disposed on the syringe housing. The light sensor module has a light sensor housing and a first sensor element and a second sensor element. The first sensor element and the second sensor element are disposed within the sensor housing. Positioning the plunger at the first position aligns the substantially translucent portion with the first sensor element and positioning the plunger at the second position aligns the substantially translucent portion with the second sensor element.
    Type: Application
    Filed: March 21, 2014
    Publication date: September 25, 2014
    Inventors: Dale Brady, Rodney L. Houfburg
  • Patent number: 8652153
    Abstract: An intervertebral disc repair system comprises an implant and a delivery tool configured to deploy the implant at least partially in a vertebral body of a patient. The implant includes an anchor member and an adjustable suture assembly coupled thereto. The delivery tool includes a proximal handle, an outer tubular member extending distally from the handle, a needle cannula slidably received within the outer tubular member having a sharpened tip for penetrating tissue (e.g., the vertebral body), an inner pusher member slidably received within the needle cannula, and an actuating mechanism coupled to the handle for selectively retracting the needle cannula relative to the outer tubular member and the inner pusher member. At least the anchor member of the implant is releasably received within the needle cannula.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: February 18, 2014
    Assignee: Anulex Technologies, Inc.
    Inventors: Dale Brady, Lawrence W. Wales, Ishmael Bentley
  • Publication number: 20120283835
    Abstract: A system and method for securing an implantable medical device to an anatomical feature, such as bony structures and/or soft tissues near the spine. The system includes a tissue fixation device and a tissue fixation device delivery tool. The tissue fixation device includes at least one bone or tissue anchor and a connecting element coupled thereto. The tissue fixation device optionally includes a flexible anchoring strap for engaging the implantable medical device. The bone or tissue anchor are configured to be deployed into the anatomical feature, and the connecting element is tightened to secure the implantable medical device to the anatomical feature.
    Type: Application
    Filed: May 3, 2011
    Publication date: November 8, 2012
    Applicant: Anulex Technologies, Inc.
    Inventors: Ishmael Bentley, Dale Brady, Emily Daley, Mike E. Lancial, Lawrence W. Wales, Steven L. Griffith
  • Publication number: 20110172682
    Abstract: An intervertebral disc repair system comprises an implant and a delivery tool configured to deploy the implant at least partially in a vertebral body of a patient. The implant includes an anchor member and an adjustable suture assembly coupled thereto. The delivery tool includes a proximal handle, an outer tubular member extending distally from the handle, a needle cannula slidably received within the outer tubular member having a sharpened tip for penetrating tissue (e.g., the vertebral body), an inner pusher member slidably received within the needle cannula, and an actuating mechanism coupled to the handle for selectively retracting the needle cannula relative to the outer tubular member and the inner pusher member. At least the anchor member of the implant is releasably received within the needle cannula.
    Type: Application
    Filed: August 10, 2010
    Publication date: July 14, 2011
    Applicant: Anulex Technologies , Inc.
    Inventors: Dale Brady, Lawrence C. Wales, Ishmael Bentley
  • Publication number: 20020156094
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1&bgr; converting enzyme that have the Formula (I). This invention also relates to a method of treatment of stroke, reperfusion injury, Alzheimer's disease, shigellosis, inflammatory diseases, and septic shock and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1&bgr; converting enzyme.
    Type: Application
    Filed: September 25, 2001
    Publication date: October 24, 2002
    Applicant: Warner-Lambert Company
    Inventors: Hans P. Albrecht, Hamish John Allen, Kenneth Dale Brady, William Glen Harter, Catherine Rose Kostlan, Bruce David Roth, Nigel Walker
  • Patent number: 6316415
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1&bgr; converting enzyme that have the Formula (I). This invention also relates to a method of treatment of stroke, reperfusion injury, Alzheimer's disease, shigellosis, inflammatory diseases, and septic shock and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1&bgr; converting enzyme.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: November 13, 2001
    Assignees: BASF Aktiengesellschaft, Warner-Lambert Company
    Inventors: Hans P. Albrecht, Hamish John Allen, Kenneth Dale Brady, William Glen Harter, Catherine Rose Kostlan, Bruce David Roth, Nigel Walker
  • Patent number: 6083981
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1.beta. converting enzyme that have the Formula I, II, or III. ##STR1## This invention also relates to a method of treatment of stroke, inflammatory diseases, septic shock reperfusion injury, Alzheimer's disease, and shigellosis, and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1.beta. converting enzyme.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: July 4, 2000
    Assignee: Warner-Lambert Company
    Inventors: Hamish John Allen, Kenneth Dale Brady, William Glen Harter, Elizabeth Ann Lunney, Mark Stephen Plummer, Tomi Sawyer, Aurash Shahripour, Nigel Walker
  • Patent number: 5932549
    Abstract: The present invention relates to N-substituted derivatives of glutamic acid of pharmaceutical interest, to pharmaceutical compositions which include compounds of the invention and pharmaceutically acceptable carriers, to methods of their preparation, and to their use in purification of interleukin-1.beta. converting enzyme (ICE).
    Type: Grant
    Filed: April 27, 1998
    Date of Patent: August 3, 1999
    Assignees: Warner-Lambert Company, BASF Aktiengesellschaft
    Inventors: Hamish John Allen, Subhashis Banerjee, Kenneth Dale Brady, John Cooke Hodges, Catherine Rose Kostlan, Robert Vincent Talanian
  • Patent number: 5919790
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1.beta. converting enzyme that have the Formula II ##STR1## This invention also relates to a method of treatment of stroke, inflammatory diseases, septic shock, reperfusion injury, Alzheimer's disease, shigellosis, and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1.beta. converting enzyme.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: July 6, 1999
    Assignees: Warner-Lambert Company, BASF Aktiengesellsschaft
    Inventors: Hamish John Allen, Kenneth Dale Brady, Bradley William Caprathe, Paul Galatsis, John Lodge Gilmore, Sheryl Jeanne Hays, Robert Vincent Talanian, Nigel Walker, Joseph Scott Warmus
  • Patent number: 5798247
    Abstract: Organic chemical compounds with ICE-inhibitory action which have structures such that they enter into an interaction with binding sites in a binding cavity.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: August 25, 1998
    Assignee: BASF Aktiengesellschaft
    Inventors: Hans-Peter Albrecht, Hans-Joachim Bohm, Kenneth Dale Brady, Peter Eckard, Kurt Ritter, Robert Vincent Talanian, Nigel Walker
  • Patent number: 5744451
    Abstract: The present invention relates to N-substituted derivatives of glutamic acid of pharmaceutical interest, to pharmaceutical compositions which include compounds of the invention and pharmaceutically acceptable carriers, to methods of their preparation, and to their use in purification of interleukin-1.beta. converting enzyme (ICE).
    Type: Grant
    Filed: August 13, 1996
    Date of Patent: April 28, 1998
    Assignees: Warner-Lambert Company, BASF A.G.
    Inventors: Hamish John Allen, Subhashis Banerjee, Kenneth Dale Brady, John Cooke Hodges, Catherine Rose Kostlan, Robert Vincent Talanian